About Indipharma
Indipharma is a Healthcare company. Manufacturer of pharmaceutical formulations and topical applications. Indipharma has raised $1.49 million across 1 funding round. The company has 249 employees. Its Indian entity Indi Pharma Private Limited reported revenue of ₹26.28 Cr. Indipharma offers products and services including Formulations and Topical Applications. Its focus areas include Traditional Pharmaceuticals.
Company details
Pharmaceutical formulations and topical applications are produced by Indipharma within the healthcare sector. Medications in forms such as tablets are developed to meet various medical requirements. Manufacturing operations emphasize quality standards across selected therapeutic categories. Essential medicines are made accessible through established production processes. The companys activities center on formulation development and dosage production for diverse needs.
- Employees 249
- SectorsHealthcare
- Website indipharma.com
- Legal Name Indi Pharma Pvt. Ltd
- Date of Incorporation 09 Jan, 1984
- Jurisdiction Goa, India
- Indian entity revenue₹26.28 Cr
FY 2024 · -6% YoY
- Indian entity net profit₹42.5 Lakh
FY 2024 · 2% margin
- Indian entity EBITDA₹1.06 Cr
FY 2024 · 4% margin
- Total Equity Funding$1.49M (USD)
in 1 rounds
- Latest Funding Round$1.49M (USD), Seed
Mar 2012
- Employee Count249
Associated legal entities of Indipharma
Indipharma operates through Indi Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indi Pharma Private Limited CIN U24232GA1984PTC000556 | Active | 09 Jan 1984 | ₹26.3 Cr | 249 | 4 | View details |
Products & Services of Indipharma
Indipharma offers a comprehensive portfolio of products and services, including Formulations and Topical Applications.
High-quality formulations are provided to address various medical needs in the pharmaceutical sector
Topical applications are offered as part of the company's focus on medicinal solutions
Funding Insights of Indipharma
Indipharma has successfully raised a total of $1.49M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.49 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.49M
- Total Rounds 1
- Last Round Seed — $1.49M
- First Round $1.49M
(Mar 2012)
All 1 funding rounds of Indipharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $1.49M | Seed | – | – | – |
Board of directors of Indi Pharma Private Limited (Indipharma)
Indi Pharma Private Limited is the primary company behind Indipharma. The board of Indi Pharma Private Limited currently have 4 directors; the longest-serving is Antonio Xavier Paulo Fernandes, appointed in 2000. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Antonio Xavier Paulo Fernandes DIN 00407426 | Director | 30 Sep 2000 | 26 yrs | Indi Pharma Private Limited |
| Maria Emilia Dias Menezes DIN 00419902 | Managing Director | 15 Jun 2005 | 21 yrs 4 mo | Indi Pharma Private Limited |
| Cesar Mauricio Jose De Menezes DIN 00407272 | Director | 15 Mar 2006 | 20 yrs 7 mo | Indi Pharma Private Limited |
| Ramakrishna Vasudev Bhat DIN 08581846 | Managing Director | 30 Sep 2021 | 5 yrs 1 mo | Indi Pharma Private Limited |
Financials of Indipharma
Figures of Indi Pharma Private Limited, the primary company behind Indipharma, for FY 2024. Revenue was ₹26.28 Cr (-6% year on year). Net profit was ₹42.5 Lakh (2% margin). EBITDA was ₹1.06 Cr (4% margin). Revenue has grown at a compounded annual rate of -11% over three years and -3% over five years.
- ₹26.28 CrRevenue · FY 2024 · -6% YoY
- ₹42.5 LakhNet profit · 2% margin
- ₹1.06 CrEBITDA · 4% margin
- ₹19.7 LakhPaid-up capital
- 249Employees (provident fund records)
- -11%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indi Pharma Private Limited are on its company page.
Detailed financial statements for Indipharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Indipharma
The website of Indipharma (indipharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 8.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indipharma
Indipharma is a funded company, having raised a total of $1.49M across 1 funding round to date. The company's 1st funding round was a Seed of $1.49M, raised on Mar 2012.
Indipharma has 249 employees.
The primary company behind Indipharma, Indi Pharma Private Limited, reported revenue of ₹26.28 Cr for FY 2024, down 6% year on year.
Pharmaceutical formulations and topical applications are produced by Indipharma within the healthcare sector. Medications in forms such as tablets are developed to meet various medical requirements. Manufacturing operations emphasize quality standards across selected therapeutic categories. Essential medicines are made accessible through established production processes. The companys activities center on formulation development and dosage production for diverse needs.
Indipharma offers Formulations and Topical Applications.
Indipharma operates through Indi Pharma Private Limited.
The legal entities of Indipharma currently have 4 directors, including Ramakrishna Vasudev Bhat, Maria Emilia Dias Menezes, Antonio Xavier Paulo Fernandes and others.